Sirolimus is an immunosuppressant used to prevent organ rejection after transplantation. It works by inhibiting T-cell activation and proliferation, thereby suppressing the immune response. Sirolimus is effective in managing transplant rejection and certain cancers. In summary, Sirolimus is beneficial for preventing organ rejection.
Sirolimus inhibits mTOR (mammalian target of rapamycin), blocking T-cell activation and reducing the immune response.
No published brands for this salt yet.